Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Balance Training for Chronic Obstructive Pulmonary Disease (COPD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02080442
Recruitment Status : Completed
First Posted : March 6, 2014
Last Update Posted : March 6, 2014
Sponsor:
Collaborator:
Ontario Lung Association
Information provided by (Responsible Party):
Samantha Harrison, West Park Healthcare Centre

Brief Summary:
The study will involve direct knowledge translation of a laboratory-based study of balance training for patients with COPD, first to the investigators PR program and then, after disseminating the results, this approach could be used to impact on clinical practice in any PR program.

Condition or disease Intervention/treatment
Chronic Obstructive Pulmonary Disease Other: Balance training

Layout table for study information
Study Type : Observational
Actual Enrollment : 19 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Balance Training for COPD in Pulmonary Rehabilitation (PR): An Effectiveness Study
Study Start Date : May 2013
Actual Primary Completion Date : February 2014
Actual Study Completion Date : February 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Lung Diseases

Group/Cohort Intervention/treatment
Chronic Obstructive Pulmonary Disease Other: Balance training
Training will consist of 30 minute sessions 2-3 times/week for a total of 18-24 sessions, in keeping with best practice guidelines for older adults.12 Sessions will be supervised by physical therapists, using a circuit training approach with different stations designed to target specific areas of impairment. Participants will work through stations in a group setting; however, will receive individualized exercise prescription regarding level of difficulty and exercise progression.




Primary Outcome Measures :
  1. Berg Balance Scale (BBS) [ Time Frame: at 6 weeks ]
    The BBS was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.

  2. Timed Up and Go (TUG): [ Time Frame: at 6 weeks ]
    The TUG was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.


Secondary Outcome Measures :
  1. The Balance Evaluation Systems Test (BESTest) [ Time Frame: at 6 weeks ]
    The BESTest was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.

  2. Activity-specific Balance Confidence (ABC) Scale [ Time Frame: at 6 weeks ]
    The ABC scale was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.


Other Outcome Measures:
  1. Balance training progression: the training prescription and progression will be recorded [ Time Frame: at 6 weeks ]
  2. Therapists' and the participants' satisfaction [ Time Frame: at 6 weeks ]

    Patients completed a questionnaire following completion of the balance training which took place thrice weekly for a period of 6 weeks.

    The focus group was conducted at the end of study recruitment.


  3. Safety: any adverse events associated with balance training will be recorded [ Time Frame: at 6 weeks ]
  4. Applicability and adherence [ Time Frame: at 6 weeks ]
  5. The Six-Minute Walk Test (6MWT) [ Time Frame: at 6 weeks ]
    The 6MWT was assessed by the physiotherapists responsible for delivering the PR program. The PR programs runs over 6 weeks.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with COPD enrolled in PR
Criteria

Inclusion Criteria:

  • Diagnosis of COPD
  • Self-report of decline in balance or fall in the last 5 years or a recent near fall
  • Smoking history greater than 10 pack years
  • Are able to provide written informed consent.

Exclusion Criteria:

  • An inability to communicate because of language skills, hearing or cognitive impairment
  • Evidence of a neurological or musculoskeletal condition that severely limits mobility and postural control (e.g., cerebrovascular accident, advanced Parkinson's disease, amputation).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02080442


Locations
Layout table for location information
Canada, Ontario
West Park Healthcare Center
Toronto, Ontario, Canada, M6M 2J5
Sponsors and Collaborators
Samantha Harrison
Ontario Lung Association

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Samantha Harrison, Ms Samantha Harrison, West Park Healthcare Centre
ClinicalTrials.gov Identifier: NCT02080442    
Other Study ID Numbers: 13-o11-WP
First Posted: March 6, 2014    Key Record Dates
Last Update Posted: March 6, 2014
Last Verified: March 2014
Keywords provided by Samantha Harrison, West Park Healthcare Centre:
COPD
Balance
Pulmonary Rehabilitation
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases